Xenon Pharmaceuticals Inc. (NASDAQ:XENE) is Driehaus Capital Management LLC's 2nd Largest Position

Driehaus Capital Management LLC boosted its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 2.3% in the second quarter, HoldingsChannel.com reports. The firm owned 4,760,853 shares of the biopharmaceutical company’s stock after buying an additional 105,928 shares during the quarter. Xenon Pharmaceuticals comprises about 2.3% of Driehaus Capital Management LLC’s investment portfolio, making […]

Related Keywords

Canada , ,Royal Bank ,Cubist Systematic Strategies ,Xenon Pharmaceuticals Stock Performance ,Driehaus Capital Management ,Nasdaq ,Wells Fargo Company ,News Ratings For Xenon Pharmaceuticals Daily ,Xenon Pharmaceuticals ,Needham Company ,Xenon Pharmaceuticals Inc ,Quarter For Xenon Pharmaceuticals ,Xenon Pharmaceuticals Profile ,Cantor Fitzgerald ,Free Report ,Capital Management ,Systematic Strategies ,Get Free Report ,Pharmaceuticals Inc ,Visit Holdingschannel ,Xenon Pharmaceuticals Daily ,Nasdaq Xene ,Exene ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,